Biotechnology

Filter

Current filters:

None

Popular Filters

101 to 125 of 2444 results

Scripps Research Institute scientists reveal weak spots in Ebola's defenses

18-11-2014

Scientists at The Scripps Research Institute (TSRI) have identified weak spots on the surface of Ebola…

Anti-viralsBiotechnologyMapp BiopharmaceuticalResearchTropical diseasesZMapp

Dicerna licenses rights to Tekmira technology

Dicerna licenses rights to Tekmira technology

18-11-2014

US RNAi therapeutics specialist Dicerna Pharmaceuticals has entered a licensing agreement for to use…

BiotechnologyDCR-PH1Dicerna PharmaceuticalsLicensingRare diseasesTekmira PharmaceuticalsUSA

Merck enters lucrative cancer alliance with Pfizer

Merck enters lucrative cancer alliance with Pfizer

17-11-2014

Germany’s Merck KGaA said today that it has entered into a global agreement with US pharma giant Pfizer…

BiotechnologyGermanyLicensingMarkets & MarketingMerck KGaAMerck SeronoMSB0010718COncologyPfizerUSAXalkori

Valeant buys NicOx’ US ophthalmic diagnostics unit

17-11-2014

Ophthalmology-focused French biotech firm NicOx says that Canada’s Valeant Pharmaceuticals International…

BiotechnologyMergers & AcquisitionsNicOxOphthalmicsUSAValeant Pharmaceuticals InternationalVesneo

Yet another indication for Roche’s blockbuster Avastin from FDA

16-11-2014

The US Food and Drug Administration on Friday approved Avastin (bevacizumab) solution for intravenous…

AvastinBiotechnologyEli LillyGemzarGenentechOncologyRegulationRocheUSA

FDA at last approves Genzyme’s Lemtrada

FDA at last approves Genzyme’s Lemtrada

15-11-2014

The US Food and Drug Administration on Friday approved French pharma major Sanofi subsidiary Genzyme’s…

BayerBiotechnologyGenzymeLemtradaNeurologicalRegulationSanofiUSA

Bristol-Myers plans biologics manufacturing facility in Ireland

14-11-2014

US pharma major Bristol-Myers Squibb plans to construct a new state-of-the-art, large-scale biologics…

BiotechnologyBristol-Myers SquibbIrelandProduction

Onxeo receives $25M milestone payment from Spectrum on Beleodaq

14-11-2014

Onxeo, created by a merger between French company BioAlliance Pharma, and Danish biopharmaceutical company…

BeleodaqBiotechnologyFinancialHematologyLicensingOncologyOnxeoSpectrum PharmaceuticalsUSA

Geron in up to $935 million deal with Janssen for imetelstat

Geron in up to $935 million deal with Janssen for imetelstat

14-11-2014

Geron Corp has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech,…

BiotechnologyGeron CorpGlobalHematologyimetelstatJanssen BiotechJohnson & JohnsonLicensingOncology

ValiRx to collaborate with Deutsches Krebsforschungzentrum on further development of GeneICE

ValiRx to collaborate with Deutsches Krebsforschungzentrum on further development of GeneICE

13-11-2014

Cancer diagnostics and personalized medicines specialist ValiRx has agreed to collaborate with Deutsches…

BiologyBiotechnologyGermanyMedicineMolecular geneticsOncologyResearchValiRx

Boehringer Ingelheim drops option for Athera’s PC-MAb

12-11-2014

Sweden’s Athera Biotechnologies, which is 65% owned by Karolinska Development, says that German family-owned…

Athera BiotechnologiesBiotechnologyBoehringer IngelheimCardio-vascularLicensing

AstraZeneca and Amgen's  brodalumab achieves primary endpoint in Phase III trial for plaque psoriasis

AstraZeneca and Amgen's brodalumab achieves primary endpoint in Phase III trial for plaque psoriasis

12-11-2014

Anglo-Swedish drug major AstraZeneca and USA-based Amgen, the world’s largest independent biotech firm,…

AmgenAstraZenecaBiotechnologybrodalumabDermatologicalsResearchStelara

Servier gains ex-US/Japan rights to Intarcia diabetes product ITCA 650

Servier gains ex-US/Japan rights to Intarcia diabetes product ITCA 650

12-11-2014

USA-based biotech firm Intarcia Therapeutics has started a strategic partnership with French independent…

BiotechnologyDiabetesexenatide pumpFranceIntarcia TherapeuticsITCA 650LicensingServier

AVEO inks deal with Ophthotech for tivozanib in ocular diseases

AVEO inks deal with Ophthotech for tivozanib in ocular diseases

11-11-2014

US biotech firm AVEO Oncology has entered into a research and exclusive option agreement with Ophthotech…

AVEO OncologyBiotechnologyLicensingOphthalmicsOphthotechtivozanibUSA

Advantages of Gilead’s Harvoni over emerging hepatitis C treatments

Advantages of Gilead’s Harvoni over emerging hepatitis C treatments

10-11-2014

US surveyed specialists anticipate prescribing Gilead Sciences’ Harvoni to a high proportion of their…

Anti-viralsBiotechnologyGilead SciencesHarvoniJanssenMarkets & MarketingMedivirOlysioSovaldiUSA

Felicitex and Selvita collaborate on personalized cancer therapies

Felicitex and Selvita collaborate on personalized cancer therapies

07-11-2014

Privately-held, US-based quiescent cancer drug and diagnostics developer Felicitex Therapeutics has entered…

BiotechnologyFelicitex TherapeuticsOncologyResearchSelvitaUSA

Novel drugs from Anavex hope to reverse Alzheimer's damage amid a stagnant marketplace

Novel drugs from Anavex hope to reverse Alzheimer's damage amid a stagnant marketplace

06-11-2014

Alzheimer’s is not an easy disease to research and develop around. The physical and psychological manifestations…

AnavexBiotechnologyCNS DiseasesResearchUSA

Janssen’s Olysio/sofosbuvir combination cleared by FDA

Janssen’s Olysio/sofosbuvir combination cleared by FDA

06-11-2014

The Food and Drug Administration has approved US health care giant Johnson & Johnson's Olysio (simeprevir)…

Anti-viralsBiotechnologyJohnson & JohnsonMedivirOlysioRegulationsofosbuvirUSA

Genmab reports nine month interim results, including $31 million revenue increase on 2013

Genmab reports nine month interim results, including $31 million revenue increase on 2013

06-11-2014

Danish biotech company Genmab has reported its nine-month interim results, including an increase in revenue…

BiotechnologydaratumumabDenmarkDuoBodyFinancialGenmabOfatumumab Injection

101 to 125 of 2444 results

Back to top